BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 16028663)

  • 1. Vasopressin infusion in children with catecholamine-resistant septic shock.
    Vasudevan A; Lodha R; Kabra SK
    Acta Paediatr; 2005 Mar; 94(3):380-3. PubMed ID: 16028663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin in catecholamine-resistant septic and cardiogenic shock in very-low-birthweight infants.
    Meyer S; Löffler G; Polcher T; Gottschling S; Gortner L
    Acta Paediatr; 2006 Oct; 95(10):1309-12. PubMed ID: 16982509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin and terlipressin in neonates and children with refractory septic shock.
    Biban P; Gaffuri M
    Curr Drug Metab; 2013 Feb; 14(2):186-92. PubMed ID: 23439212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis.
    Dünser MW; Mayr AJ; Ulmer H; Ritsch N; Knotzer H; Pajk W; Luckner G; Mutz NJ; Hasibeder WR
    Anesth Analg; 2001 Jul; 93(1):7-13. PubMed ID: 11429329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of continuous vasopressin infusion in patients with septic shock.
    Obritsch MD; Jung R; Fish DN; MacLaren R
    Ann Pharmacother; 2004; 38(7-8):1117-22. PubMed ID: 15178740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose vasopressin in the treatment of vasodilatory septic shock.
    Malay MB; Ashton RC; Landry DW; Townsend RN
    J Trauma; 1999 Oct; 47(4):699-703; discussion 703-5. PubMed ID: 10528604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock.
    Tsuneyoshi I; Yamada H; Kakihana Y; Nakamura M; Nakano Y; Boyle WA
    Crit Care Med; 2001 Mar; 29(3):487-93. PubMed ID: 11373409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of terlipressin in the treatment of infants and neonates with catecholamine-resistant septic shock.
    Leone M; Martin C
    Best Pract Res Clin Anaesthesiol; 2008 Jun; 22(2):323-33. PubMed ID: 18683478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rescue therapy with terlipressin by continuous infusion in a child with catecholamine-resistant septic shock.
    Zeballos G; López-Herce J; Fernández C; Brandstrup KB; Rodríguez-Núñez A
    Resuscitation; 2006 Jan; 68(1):151-3. PubMed ID: 16325320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes insipidus after discontinuation of vasopressin infusion for septic shock.
    Rana H; Ferguson N; Dicpinigaitis PV
    J Clin Pharm Ther; 2018 Apr; 43(2):287-290. PubMed ID: 28895166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Indications of vasopressin in the management of septic shock].
    Delmas A; Leone M; Rousseau S; Albanèse J; Martin C
    Ann Fr Anesth Reanim; 2003 Jul; 22(7):600-8. PubMed ID: 12946492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of vasopressin in the management of septic shock.
    Mutlu GM; Factor P
    Intensive Care Med; 2004 Jul; 30(7):1276-91. PubMed ID: 15103461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin in catecholamine-refractory shock in children.
    Meyer S; Gortner L; McGuire W; Baghai A; Gottschling S
    Anaesthesia; 2008 Mar; 63(3):228-34. PubMed ID: 18081903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the Addition of Vasopressin to Catecholamine Vasopressors Affect Outcomes in Patients With Distributive Shock?
    Roumpf SK; Hunter BR
    Ann Emerg Med; 2019 Jul; 74(1):153-155. PubMed ID: 30446352
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic applications of vasopressin in pediatric patients.
    Agrawal A; Singh VK; Varma A; Sharma R
    Indian Pediatr; 2012 Apr; 49(4):297-305. PubMed ID: 22565074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin in hemorrhagic shock.
    Sharma RM; Setlur R
    Anesth Analg; 2005 Sep; 101(3):833-834. PubMed ID: 16116000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of terlipressin in pediatric septic shock: a review of the literature and personal experience.
    Papoff P; Mancuso M; Barbara CS; Moretti C
    Int J Immunopathol Pharmacol; 2007; 20(2):213-21. PubMed ID: 17624234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressin as an inotrope in refractory septic shock.
    Habaragamuwa BW; Lamahewage N; Piyasiri CA
    Ceylon Med J; 2010 Mar; 55(1):31-2. PubMed ID: 20449918
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemodynamic and metabolic effects of vasopressin infusion in children with shock.
    Baldasso E; Ramos Garcia PC; Piva JP; Einloft PR
    J Pediatr (Rio J); 2007 Nov; 83(5 Suppl):S137-45. PubMed ID: 18038019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II and Vasopressin for Vasodilatory Shock: A Critical Appraisal of Catecholamine-Sparing Strategies.
    Heavner MS; McCurdy MT; Mazzeffi MA; Galvagno SM; Tanaka KA; Chow JH
    J Intensive Care Med; 2021 Jun; 36(6):635-645. PubMed ID: 32223515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.